title: Effects of atelocollagen formulation containing oligonucleotide on endothelial permeability.
abstract: Atelocollagen is a major animal protein that is used as a highly biocompatible biomaterial. To date, atelocollagen has been used as an effective drug delivery technology to sustain the release of antitumor proteins and to enhance the antitumor activity of oligonucleotides in in vivo models. However, the biological effects of this technology are not fully understood. In the present study, we investigated the effects of atelocollagen on endothelial paracellular barrier function. An atelocollagen formulation containing oligonucleotides specifically increased the permeability of two types of endothelial cells, and the change was dependent on the molecular size, structure of the oligonucleotides used and the concentrations of the oligonucleotide and atelocollagen in the formulation. An immunohistochemical examination revealed that the formulation had effects on the cellular skeleton and intercellular structure although it did not affect the expression of adherens junction or tight junction proteins. These changes were induced through p38 MAP kinase signaling. It is important to elucidate the biological functions of atelocollagen in order to be able to exploit its drug delivery properties.
authors.affiliation: Formulation Research and Development Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 1-3-45 Kurakakiuchi, Ibaraki-shi, Osaka 567-0878, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Hanai
authors.forename: Takashi
authors.initials: T
authors.lastname: Kojima
authors.forename: Mika
authors.initials: M
authors.lastname: Ota
authors.forename: Jun
authors.initials: J
authors.lastname: Onodera
authors.forename: Norimasa
authors.initials: N
authors.lastname: Sawada